• 中国资本市场开放出大招 跨境证券投资更便利 2019-10-13
  • 世卫将“游戏障碍”列为新疾病 哪些症状可被确诊? 2019-10-13
  • 景区去门票化积弊短期难除 如何摆脱门票依赖? 2019-10-08
  • 东风路老旧小区欲华丽变身 微改造项目勘察设计已招标 ——凤凰网房产广州 2019-10-08
  • 翔龙无人机服役后首次曝光,大幅提升空军情报收集能力 2019-09-19
  • 证监会去年对外公开监管信息14560条 2019-09-19
  • 人民网欧洲中心分社记者报道集 2019-09-06
  • 图解:短视频平台频遭约谈敲响警钟,野蛮生长要不得! 2019-09-06
  • 中考期间广州部分公交线路有调整 2019-09-01
  • 减肥必备!这十种食物饱口福还能吃出好身材 2019-09-01
  • “蛟龙” 吸引世界目光(砥砺奋进的五年·重大工程巡礼) 2019-08-19
  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置时时彩网络平台>技术资料首页>行业动态>新品动态>Life Technologies推出Applied Biosystems SOLiD PI系统

    江苏福彩快三开奖结果: Life Technologies推出Applied Biosystems SOLiD PI系统

    Life Technologies2010年2月25日 9:59 点击:2794

    时时彩网络平台 www.qlgr.net 美国Life Technologies 美国应用生物系统公司Applied Biosystems ABI  
    Life Technologies宣布,计划推出Applied Biosystems SOLiD系统,这套新的基因体分析平台系统,准确度高,具有弹性,而且容易操作;初期采用新系统的客户为SOLiD PI System,将在2010年下半年开始使用。

    Life Technologies新闻稿
    Life Technologies Debuts the SOLiD(TM) PI System, Expands Genetic Sequencing PortfolioPowerful,
    cost-effective system to provide highest accuracy sequencing data for range of applications


     

    CARLSBAD, Calif., Feb 24, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    The SOLiD PI System, designed in partnership with Hitachi High-Technologies Corporation, will provide individual researchers and sequencing core laboratories with a cost-effective instrument that will deliver an accuracy level of 99.99 percent. The system uses the same highly-accurate ligation-based sequencing technology as the SOLiD 4 System, and coupled with a streamlined workflow, is engineered to deliver high-quality, sample-to-mapped data in as little as two days. Designed to generate up to 50 gigabases (Gb) of mappable sequence data per run, equivalent to up to 8 Gb per day, this powerful, yet intuitive system will support a breadth of next-generation sequencing applications that include, SNP calling and detection, targeted resequencing, whole transcriptome analysis and digital gene expression analysis.

    The system also addresses the challenges related to capital and run costs facing scientists engaged in next-generation sequencing. The SOLiD PI System is anticipated to deliver a next-generation sequencer at a US list price of $230,000, with a cost per sample as low as $200.

    "As sequencing becomes an ever more important tool for scientists to unlock the mechanisms of disease, it is critical that we provide a range of system solutions that meet the unique requirements of individual researchers," said Kip Miller, President of the Genetic Systems Division for Life Technologies. "The SOLiD PI System builds on the superior data quality and accuracy of our SOLiD system chemistry, but delivers it in a more affordable format that will bring the power of next-generation sequencing to every laboratory."

    The SOLiD PI System is the latest addition to Life Technologies' portfolio of sequencing solutions. The company recently announced the introduction of the SOLiD 4 System, which delivers unprecedented accuracy in next-generation sequencing. These offerings, along with the company's gold-standard capillary electrophoresis (CE) instrumentation, demonstrate Life Technologies' commitment to innovation across the research continuum, supporting sequencing analysis from discovery through validation and screening.

    For more information on the SOliD PI System please visit //www.appliedbiosystems.com/solidpi

    About Life Technologies (//www.lifetech.com)

    Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit us online at //www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

    Life Technologies' Safe Harbor Statement

    This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

    For Research Use Only. Not for use in diagnostic procedures.

    Photos/Multimedia Gallery Available: //www.businesswire.com/cgi-bin/mmg.cgi?eid=6189478&lang=en

    SOURCE: Life Technologies Corporation

    Life Technologies CorporationPatty Zamora, 760-476-7818[email protected]

    (来源: Life Technologies )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, 时时彩网络平台,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


  • 中国资本市场开放出大招 跨境证券投资更便利 2019-10-13
  • 世卫将“游戏障碍”列为新疾病 哪些症状可被确诊? 2019-10-13
  • 景区去门票化积弊短期难除 如何摆脱门票依赖? 2019-10-08
  • 东风路老旧小区欲华丽变身 微改造项目勘察设计已招标 ——凤凰网房产广州 2019-10-08
  • 翔龙无人机服役后首次曝光,大幅提升空军情报收集能力 2019-09-19
  • 证监会去年对外公开监管信息14560条 2019-09-19
  • 人民网欧洲中心分社记者报道集 2019-09-06
  • 图解:短视频平台频遭约谈敲响警钟,野蛮生长要不得! 2019-09-06
  • 中考期间广州部分公交线路有调整 2019-09-01
  • 减肥必备!这十种食物饱口福还能吃出好身材 2019-09-01
  • “蛟龙” 吸引世界目光(砥砺奋进的五年·重大工程巡礼) 2019-08-19
  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 广西快3开奖官方同步 打电子游戏的坏处 青海十一选五十分钟开一次 大乐透16021期重点号码 买七星彩 五星组选包胆保守倍投 秒速时时票官网网址 年黄大仙一肖中特 山东群英会20选5走势图 香港六和合曾道人资料 快乐时时彩官网下载手机版 彩app哪个是正规的 捕鱼达人开发 2019开码结果查询开奖 彩票浙江11选5开奖结果